Rep. Robert Bresnahan, Jr. Sells Molina Healthcare, Inc. (NYSE:MOH) Shares

Representative Robert Bresnahan, Jr. (R-Pennsylvania) recently sold shares of Molina Healthcare, Inc. (NYSE:MOH). In a filing disclosed on February 13th, the Representative disclosed that they had sold between $1,001 and $15,000 in Molina Healthcare stock on January 13th. The trade occurred in the Representative’s “JOINT OWNERSHIP LPL ACCOUNT” account.

Representative Robert Bresnahan, Jr. also recently made the following trade(s):

• Sold $15,001 – $50,000 in shares of Lowe’s Companies (NYSE:LOW) on 2/7/2025.
• Purchased $1,001 – $15,000 in shares of Intel (NASDAQ:INTC) on 2/3/2025.
• Purchased $1,001 – $15,000 in shares of Take-Two Interactive Software (NASDAQ:TTWO) on 2/3/2025.
• Purchased $1,001 – $15,000 in shares of ServiceNow (NYSE:NOW) on 2/3/2025.
• Sold $1,001 – $15,000 in shares of Microsoft (NASDAQ:MSFT) on 1/30/2025.
• Purchased $1,001 – $15,000 in shares of Alibaba Group (NYSE:BABA) on 1/30/2025.
• Purchased $1,001 – $15,000 in shares of Alibaba Group (NYSE:BABA) on 1/29/2025.
• Sold $1,001 – $15,000 in shares of Credo Technology Group (NASDAQ:CRDO) on 1/29/2025.
• Sold $1,001 – $15,000 in shares of Manhattan Associates (NASDAQ:MANH) on 1/29/2025.
• Sold $1,001 – $15,000 in shares of NVIDIA (NASDAQ:NVDA) on 1/29/2025.

Molina Healthcare Stock Performance

Shares of NYSE:MOH opened at $272.28 on Friday. The stock has a market capitalization of $15.57 billion, a P/E ratio of 13.33, a P/E/G ratio of 0.94 and a beta of 0.54. Molina Healthcare, Inc. has a 1-year low of $262.32 and a 1-year high of $423.92. The company has a current ratio of 1.62, a quick ratio of 1.55 and a debt-to-equity ratio of 0.69. The business has a 50-day moving average price of $295.26 and a two-hundred day moving average price of $316.72.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $5.05 earnings per share for the quarter, missing the consensus estimate of $5.74 by ($0.69). Molina Healthcare had a return on equity of 28.13% and a net margin of 2.90%. Equities analysts predict that Molina Healthcare, Inc. will post 24.5 earnings per share for the current year.

Hedge Funds Weigh In On Molina Healthcare

Several institutional investors and hedge funds have recently modified their holdings of the business. Becker Capital Management Inc. boosted its position in Molina Healthcare by 0.7% during the 4th quarter. Becker Capital Management Inc. now owns 43,057 shares of the company’s stock worth $12,532,000 after acquiring an additional 320 shares during the last quarter. Voleon Capital Management LP acquired a new position in Molina Healthcare during the 4th quarter worth approximately $308,000. PDT Partners LLC boosted its position in Molina Healthcare by 124.6% during the 4th quarter. PDT Partners LLC now owns 3,600 shares of the company’s stock worth $1,048,000 after acquiring an additional 1,997 shares during the last quarter. AQR Capital Management LLC boosted its position in Molina Healthcare by 19.6% during the 4th quarter. AQR Capital Management LLC now owns 620,294 shares of the company’s stock worth $180,537,000 after acquiring an additional 101,630 shares during the last quarter. Finally, Lido Advisors LLC boosted its position in Molina Healthcare by 52.3% during the 4th quarter. Lido Advisors LLC now owns 1,448 shares of the company’s stock worth $422,000 after acquiring an additional 497 shares during the last quarter. 98.50% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

MOH has been the subject of several recent research reports. StockNews.com cut Molina Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, February 8th. Wells Fargo & Company upped their price target on Molina Healthcare from $360.00 to $362.00 and gave the company an “equal weight” rating in a research note on Monday, November 4th. Truist Financial lowered their price target on Molina Healthcare from $400.00 to $370.00 and set a “buy” rating for the company in a research note on Monday, January 6th. JPMorgan Chase & Co. reaffirmed a “neutral” rating and issued a $350.00 price target (down from $378.00) on shares of Molina Healthcare in a research note on Tuesday, December 17th. Finally, Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $406.00 price target on shares of Molina Healthcare in a research note on Thursday, October 24th. One analyst has rated the stock with a sell rating, seven have assigned a hold rating, five have given a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and an average price target of $355.67.

About Representative Bresnahan

Rob Bresnahan Jr. (Republican Party) is a member of the U.S. House, representing Pennsylvania’s 8th Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.

Bresnahan (Republican Party) is running for re-election to the U.S. House to represent Pennsylvania’s 8th Congressional District. He declared candidacy for the 2026 election.

Rob Bresnahan Jr. was born in Kingston, Pennsylvania. He earned a B.S. in business administration, management and operations from the University of Scranton in 2012. His career experience includes working as the chief financial officer and CEO of a family business, an electrical contracting company.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.